Search results
Matthew T. Drake, M.D., Ph.D., studies bone loss across both normal and disease states. Specifically, Dr. Drake is interested in the mechanisms underlying age-related bone loss and the skeletal microarchitectural changes that accompany this condition.
Associate Member Mayo Clinic Center for Translational Science Activities 2007 - present Member Metabolic Bone Disease Core Group, Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine
Matthew Drake, M.D., Ph.D. – Mayo Clinic. Dr. Matthew T. Drake is a Consultant in the Division of Endocrinology and Associate Professor of Medicine. He has a joint appointment in the Division of Hematology, where he sees patients with MGUS and myeloma-associated bone disease.
Monoclonal Gammopathy of Undetermined Significance: Indications for Prediagnostic Testing, Subsequent Diagnoses, and Follow-up Practice at Mayo Clinic. Mayo Clin Proc. 2020 May; 95 (5):944-954 View PubMed
Feb 19, 2010 · A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival. The results were presented at the annual meeting of the American Society of Hematology in New Orleans.
Matthew T Drake, MD, PhD Curriculum Vitae and Bibliography. Present Academic Rank and Position. Consultant - Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal...
Dive into the research topics where Matthew M Drake is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
